Literature DB >> 6315736

Innocuity testing of foot-and-mouth disease vaccines. I. Formaldehyde-inactivated alhydrogel vaccines.

S J Barteling, R Woortmeyer, N Visser.   

Abstract

Conditions that contribute to efficient innocuity testing of formaldehyde (FA)-inactivated alhydrogel vaccines were investigated. Under our conditions good yields of 146S antigen were obtained if the antigen was eluted by potassium phosphate buffer (pH 7.4) and concentrated by ultrafiltration. Non-inactivated virus added to the vaccine and adsorbed overnight could be recovered if residual FA was removed from the vaccine by washing the gel thoroughly with Frenkel culture medium before the addition of the virus. It was shown that the presence of high concentrations of inactivated virus in the concentrated eluate could prevent the detection of small amounts infectious virus in intradermolingual tests in cattle. This interference phenomenon was not found if (more susceptible) monolayers of foetal calf thyroid cells were used for the detection of virus. Intensive pre-washing of the gel with Frenkel culture medium, elution with potassium phosphate, concentration by ultrafiltration and the use of thyroid cells for the final detection of surviving virus is therefore advised for safety testing.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315736     DOI: 10.1016/s0092-1157(83)80018-3

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


  3 in total

1.  Desorption of porcine parvovirus from aluminum hydroxide adjuvant with subsequent viral immunoassay or hemagglutination assay.

Authors:  J Katz
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

2.  Formaldehyde inactivation of foot-and-mouth disease virus. Conditions for the preparation of safe vaccine.

Authors:  S J Barteling; R Woortmeyer
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

3.  Confirmation of botulism diagnosis in Australian bird samples by ELISA and RT rtPCR.

Authors:  Anne M Masters; Dieter G Palmer
Journal:  J Vet Diagn Invest       Date:  2021-05-06       Impact factor: 1.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.